Fredag 29 Maj | 20:48:03 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-08-31 07:00 Kvartalsrapport 2026-Q2
2026-05-11 - X-dag ordinarie utdelning CRNA 0.00 NOK
2026-05-08 - Årsstämma
2026-04-15 - Bokslutskommuniké 2025
2026-01-12 - Extra Bolagsstämma 2026
2025-08-28 - Kvartalsrapport 2025-Q2
2025-06-06 - X-dag ordinarie utdelning CRNA 0.00 NOK
2025-06-05 - Årsstämma
2025-04-10 - Bokslutskommuniké 2024
2024-08-29 - Kvartalsrapport 2024-Q2
2024-06-19 - Årsstämma
2024-06-06 - X-dag ordinarie utdelning CRNA 0.00 NOK
2024-04-25 - Bokslutskommuniké 2023
2023-10-04 - Split CRNA 30:1
2023-08-24 - Kvartalsrapport 2023-Q2
2023-05-22 - Årsstämma
2023-04-21 - X-dag ordinarie utdelning CRNA 0.00 NOK
2023-03-09 - Extra Bolagsstämma 2023
2023-02-16 - Bokslutskommuniké 2022
2022-11-03 - Kvartalsrapport 2022-Q3
2022-08-18 - Kvartalsrapport 2022-Q2
2022-05-12 - Kvartalsrapport 2022-Q1
2022-04-20 - Årsstämma
2022-04-07 - X-dag ordinarie utdelning CRNA 0.00 NOK
2022-02-17 - Bokslutskommuniké 2021
2021-11-25 - Extra Bolagsstämma 2021
2021-11-04 - Kvartalsrapport 2021-Q3
2021-08-18 - Kvartalsrapport 2021-Q2
2021-05-06 - Kvartalsrapport 2021-Q1
2021-03-18 - X-dag ordinarie utdelning CRNA 0.00 NOK
2021-03-17 - Årsstämma
2021-02-18 - Bokslutskommuniké 2020
2020-11-05 - Kvartalsrapport 2020-Q3
2020-08-20 - Kvartalsrapport 2020-Q2
2020-05-07 - Kvartalsrapport 2020-Q1
2020-04-30 - X-dag ordinarie utdelning CRNA 0.00 NOK
2020-04-29 - Årsstämma
2020-03-11 - Bokslutskommuniké 2019
2019-11-07 - Kvartalsrapport 2019-Q3
2019-08-22 - Kvartalsrapport 2019-Q2
2019-05-09 - Kvartalsrapport 2019-Q1
2019-04-10 - X-dag ordinarie utdelning CRNA 0.00 NOK
2019-04-09 - Årsstämma
2019-02-14 - Bokslutskommuniké 2018
2018-11-01 - Kvartalsrapport 2018-Q3
2018-08-23 - Kvartalsrapport 2018-Q2
2018-05-03 - Kvartalsrapport 2018-Q1
2018-04-12 - X-dag ordinarie utdelning CRNA 0.00 NOK
2018-04-11 - Årsstämma
2018-02-15 - Bokslutskommuniké 2017
2017-11-16 - Kvartalsrapport 2017-Q3
2017-08-24 - Kvartalsrapport 2017-Q2
2017-04-25 - Kvartalsrapport 2017-Q1
2017-04-05 - Årsstämma
2017-02-16 - Bokslutskommuniké 2016
2016-11-17 - Kvartalsrapport 2016-Q3
2016-08-25 - Kvartalsrapport 2016-Q2
2016-05-12 - Kvartalsrapport 2016-Q1
2016-04-14 - X-dag ordinarie utdelning CRNA 0.00 NOK
2016-04-13 - Årsstämma
2015-06-23 - X-dag ordinarie utdelning CRNA 0.00 NOK
2015-06-22 - Årsstämma

Beskrivning

LandNorge
ListaOslo Bors
SektorHälsovård
IndustriBioteknik
Circio Holding är ett läkemedelsbolag. Bolaget specialistkompetens återfinns inom riktad immunterapi som används vid behandling av cancerpatienter. Bolagets verksamhet består av forskning och utveckling och läkemedlen säljs under separata varumärken. Ett flertal partnerskap på marknaden har ingåtts för att stärka samarbetet inom utvecklingen av ny immunterapi. Bolaget grundades 2010 och har sitt huvudkontor i Lysaker.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-05-26 07:05:00

NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, THE UNITED KINGDOM, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.

Oslo, Norway, 26 May 2026 – Circio Holding ASA (OSE: CRNA) (“Circio” or the “Company”), a biotechnology company developing novel circular RNA expression technology for gene and cell therapy, announces the commencement of the exercise period for the 67,680,945 warrants issued on ISIN NO0013711523 in connection with the rights issue and related private placement (Nw.: frittstående tegningsretter) (the “Warrants”).

The exercise window for the Warrants opens today, 26 May 2026, at 08:00 CEST. The Warrants can be exercised digitally through the systems of VPS, which are available from the websites of Pareto Securities AS (www.paretosec.com/transactions) and Circio or by completion of an exercise form (the "Exercise Form") available at the websites of Pareto Securities AS and Circio. Only Norwegian personal shareholders are able to exercise Warrants digitally through the systems of VPS.

KEY TERMS AND DATES:

  • Warrant exercise price: NOK 8.2508 per share (20% discount to VWAP 8–22 May 2026)
  • Warrant exercise period: 26 May - 9 June 2026
  • Warrant trading: The Warrants are listed and tradable on the Oslo Stock Exchange under the ticker code "CRNAS" with ISIN NO0013711523
  • Warrant trading period: The Warrants are tradable up to and including 3 June 2026
  • Unexercised Warrants: Warrants not exercised by the end of the exercise period will lapse without any compensation to the holder
  • Notification of allocation: On or about 10 June 2026
  • Warrant payment date: 12 June 2026
  • Registration of share capital increase: On or about 18 June 2026
  • First day of trading for the new shares: On or about 18 June 2026 (post completion of the share capital increase)
  • Delivery of new shares: On or about 19 June 2026

MAIN ALTERNATIVES FOR WARRANT HOLDERS:

  1. Exercise currently held Warrants during the exercise period, pay the exercise price and receive new shares in Circio.
  2. Buy additional Warrants on the Oslo Stock Exchange. Subsequently exercise all held Warrants during the exercise period, pay the exercise price and receive new shares in Circio.
  3. Sell a portion of currently held Warrants during the trading period. Subsequently exercise the remaining Warrants held during the exercise period, pay the exercise price and receive shares in Circio.
  4. Sell all currently held Warrants during the trading period on the Oslo Stock Exchange.
  5. Do nothing. Warrants not exercised by 9 June 2026 will lapse without any compensation to the holder.

INFORMATION RELATED TO FINANCING OF WARRANTS:
Exercising Warrants means buying new shares in Circio at the Exercise Price of NOK 8.2508 per share. The aggregate exercise price must be settled in cash on the Warrant payment date (12 June 2026), and investors planning to exercise Warrants must secure sufficient financing ahead of that date. Illustrative example: A holder of 100,000 Warrants would need NOK 825,080 (100,000 × NOK 8.2508) to exercise all Warrants.
 
Q&A RELATED TO THE WARRANTS:

Please visit the websites of Pareto Securities: https://paretosec.no/investeringer/emisjoner/warranter-circio-holding

 
FURTHER INFORMATION ABOUT THE WARRANTS:
The grant or purchase of Warrants by persons resident in, or who are citizens of countries other than Norway or Sweden, may be affected by the laws of the relevant jurisdiction. For a further description of such restrictions, reference is made to Section 11 "Selling and Transfer Restrictions" in the securities note dated 13 January 2026 (the "Securities Note", and together with a registration document dated 1 October 2025, and a registration document supplement and summary dated 13 January 2026, comprise the "Prospectus").
 
For more information about the Warrants, please refer to the Prospectus. The Prospectus is available on the Company's website: https://www.circio.com/en/prospectus-for-the-rights-issue-2026/.